31P MRS as an early prognostic indicator of patient response to chemotherapy
Authors:
- 1 May 1992
- journal article
- research article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 25 (1) , 30-44
Abstract
In this study 31P spectral changes were closely monitored following the initial administration of cytotoxic drugs and related to five parameters of patient response. Pre‐ and postchemotherapy 31P MRS examinations were performed on 16 patients with large, malignant tumors. These included four tumor types: (i) lymphoma (n = 7),(ii) breast carcinoma (n = 4), (iii) musculoskeletal tumors (n = 4), and (iv) adenocarcinoma (n = 1). A mean of 5 spectra/patient (range 2–10) was performed following the initial chemotherapy. The spectral trends exhibited by 14 of 16 patients reached “points of maximum change,” after which they began to revert toward prechemotherapy values. In 2 of 16 patients that did not respond to the initial chemotherapy regimen, no spectral trends were observed. The degree of change of certain spectral parameters, namely, decreases in PME, PME/ PDE, PME/PCr, PME/NTP, PDE/PCr, and tumor pH, as well as increases in the ratios Pi/PME and Pi/PDE, were associated with good patient response and separated responders from nonresponders. Pi/PME appears the most promising for discriminating partial from Complete responders.Keywords
This publication has 23 references indexed in Scilit:
- In vivo phosphorus-31 magnetic resonance spectroscopy of normal and pathological breast tissuesBritish Journal of Radiology, 1991
- An in vivo phosphorus nuclear magnetic resonance study of the variations with age in the phosphodiers' content of human muscleMechanisms of Ageing and Development, 1988
- BIOCHEMICAL INVESTIGATION OF HUMAN TUMOURS IN VIVO WITH PHOSPHORUS-31 MAGNETIC RESONANCE SPECTROSCOPYThe Lancet, 1986
- Tumor size dependent changes in a murine fibrosarcoma: Use of in vivo31P NMR for non-invasive evaluation of tumor metabolic statusInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1986
- Cerebral intracellular pH by 31 P nuclear magnetic resonance spectroscopyNeurology, 1985
- Phosphorylethanolamine ‐ the major constituent of the phosphomonoester peak observed by 31P‐NMR on developing dog brainFEBS Letters, 1984
- Application ofin vivo NMR spectroscopy to cancerMagnetic Resonance in Medicine, 1984
- MONITORING RESPONSE TO CHEMOTHERAPY OF INTACT HUMAN TUMOURS BY 31P NUCLEAR MAGNETIC RESONANCEThe Lancet, 1984
- 31P NMR spectroscopy of in vivo tumorsJournal of Magnetic Resonance (1969), 1982
- Mapping of metabolites in whole animals by 31P NMR using surface coilsNature, 1980